India drives earnings growth, while North America/PSAI drags it down
Dr. Reddy's Labs (DRRD) delivered a miss on earnings in 1QFY22, affected by a) higher price erosion in North America (NAM) sales, b) the deferment...
108 Views
Dr Reddys Labs: Operational Excellence and Continuous Improvement
DRRD delivered a strong performance led by the volume growth and new product launches across these markets. We expect revenue and PAT CAGR of 10.3%...
114 Views
Event Update:Dr Reddys Labs
Dr. Reddy's Laboratories Ltd (DRREDDY) offers a portfolio of products and services including APIs, custom pharmaceutical services, generics,...
207 Views
Event Update:Dr Reddys Labs
Dr. Reddy's Laboratories Ltd (DRREDDY) offers a portfolio of products and services including APIs, custom pharmaceutical services, generics,...
180 Views